New drug trial begins for Tough-to-Treat kidney cancer
Disease control
Recruiting now
This is the first study in people testing a new oral drug called NEO-811 for advanced kidney cancer that has spread or cannot be removed by surgery. The main goals are to find a safe dose and see how the body handles the drug. It is for patients whose cancer has continued to grow…
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC